Stockscreener 앱 받기
0.9096
1.13%
-0.0104
시간 외 거래:
.96
0.0504
+5.54%
Milestone Scientific Inc. 주식(MLSS)의 최신 뉴스
Major Shareholder Sells Thousands of Milestone Scientific Shares! - TipRanks
Major Shareholder Sheds Milestone Scientific Stock in Noteworthy Transaction - TipRanks
Inter Scientific Achieves UK GLP Monitoring Authority Status to Support Regulatory Studies for Medicines, Devices and Novel Products - FinancialContent
Milestone Scientific Reports Increased Quarterly Loss - TipRanks
Benchmark maintains $1.25 target on Milestone Scientific stock - Investing.com
Benchmark maintains $1.25 target on Milestone Scientific stock By Investing.com - Investing.com India
Milestone Scientific adds new board member to drive growth By Investing.com - Investing.com South Africa
Milestone Scientific adds new board member to drive growth - Investing.com Australia
Milestone Scientific Appoints New Independent Director - TipRanks
Milestone Scientific Appoints Highly Accomplished MedTech Execut - GuruFocus
Milestone Scientific Inc. Appoints Shanth Thiyagalingam to Board of Directors to Enhance Strategic Growth and Innovation - Nasdaq
Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors - GlobeNewswire
Milestone Scientific Lands PainTEQ CEO to Drive Medicare Reimbursement Strategy - Stock Titan
StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS) - Defense World
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025 - The Manila Times
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025 | MLSS Stock News - GuruFocus
Milestone Scientific Medical Sales Surge 586% After Medicare Coverage Win for CompuFlo System - Stock Titan
Rigetti Shares Down 15% Post Q1 Earnings: Time to Buy, Hold or Sell? - TradingView
Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer's Program Amid Encouraging Data - The Manila Times
Nexalin Technology Reconstitutes Scientific Advisory Board - GlobeNewswire
Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer’s Program Amid Encouraging Data - The Globe and Mail
StockNews.com Begins Coverage on Milestone Scientific (NYSE:MLSS) - Defense World
Space exploration | History, Definition, & Facts - Britannica
Renaissance Technologies LLC Buys 53,198 Shares of Milestone Scientific Inc. (NYSE:MLSS) - Defense World
Envestnet Asset Management Inc. Takes $203,000 Position in Universal Technical Institute, Inc. (NYSE:UTI) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Milestone Scientific (NYSE:MLSS) Now Covered by Analysts at StockNews.com - Defense World
Milestone Scientific Announces Pricing of Above Market $4.5 Million Offering of Common Stock and Warrants - ACCESS Newswire
Milestone Scientific Inc. to Host Earnings Call - ACCESS Newswire
Protara Therapeutics, Inc. (NASDAQ:TARA) Shares Sold by LPL Financial LLC - Defense World
Pre-market Movers: STSS, THRD, PTN, VRAX... - RTTNews
Commentary: This genetics firm didn't resurrect the extinct dire wolf, but did achieve a breakthrough in hype - Los Angeles Times
Milestone Scientific (NYSE:MLSS) Now Covered by StockNews.com - Defense World
Benchmark maintains Buy on Milestone Scientific, $1.25 target By Investing.com - Investing.com South Africa
Benchmark maintains Buy on Milestone Scientific, $1.25 target - Investing.com Australia
Charles & Colvard, Ltd. Announces Delisting from Nasdaq - Quantisnow
Milestone Scientific earnings missed by $0.01, revenue fell short of estimates - Investing.com Canada
Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025 - The Manila Times
Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025 | MLSS Stock News - GuruFocus
Milestone Scientific Reports Year-End 2024 Financial Results And Reports Strong Outlook For 2025 - marketscreener.com
Milestone Scientific Inc. Expands CompuFlo® Epidural System Adoption Following Medicare Price Approvals in Multiple States - Nasdaq
Milestone Medical, Inc. Announces Management Changes - marketscreener.com
Jupiter Neurosciences Highlights Upcoming Milestones in Shareholder Letter - GlobeNewswire
Milestone Scientific Announces Validation and Implementation of Quick Start to the CompuFlo Epidural System - ACCESS Newswire
‘A revolutionary milestone’: Colossal Biosciences announces de-extinction of the dire wolves - KXAN Austin
Colossal Announces World’s First De-Extinction: Birth of Dire Wolves - Business Wire
cbdMD Achieves Key Milestone in UK Novel Food Regulatory Approval - TradingView
Milestone Pharmaceuticals downgraded to Hold from Buy at TD Cowen - Yahoo Finance
IAC completes spin-off of Angi Inc. - Yahoo Finance
Milestone Scientific expands CompuFlo Epidural System footprint with InfiniSurg - Yahoo Finance
Milestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey - The Manila Times
1.19%
0.75%
자본화:
|
볼륨(24시간):